Table 5.
Influence of various immunological cells in ascitic fluids on overall survival using multivariate model with coefficient of determination of 0.65 with a significance level of p < 0.001
| HR | 95% CI | p | |
|---|---|---|---|
| CD4+RO | 0.954 | 0.877–1.037 | 0.272 |
| CD4+RA | 1.037 | 0.924–1.164 | 0.539 |
| CD3+CD69+ | 1.074 | 0.967–1.193 | 0.173 |
| CD8+CD57+ | 1.092 | 0.789–1.153 | 0.596 |
| CD3+CD25+ | 0.848 | 0.603–1.192 | 0.330 |
| CD8+DR+ | 0.897 | 0.332–2.424 | 0.830 |
| CD3+DR+ | 1.066 | 0.472–2.411 | 0.878 |
| CD3+CD16+CD56+ | 1.335 | 1.079–1.652 | 0.014 |
| CD3–CD16+CD56+ | 0.692 | 0.543–0.880 | 0.003 |
| CD3–CD8+ | 1.314 | 1.021–1.691 | 0.044 |
| CD3+CD8+ | 0.850 | 0.753–0.959 | 0.002 |
| CD19+ | 1.085 | 0.947–1.243 | 0.225 |
| CD8+ | 1.021 | 0.927–1.123 | 0.674 |
| CD4+ | 1.213 | 1.038–1.416 | 0.010 |
| CD3+ | 1.000 | 0.895–1.119 | 0.995 |